tiprankstipranks
Advertisement
Advertisement

ONCY Stock Latest News

Oncolytics Biotech Secures New Pelareorep Manufacturing Patent
Company AnnouncementsOncolytics Biotech Secures New Pelareorep Manufacturing Patent
10d ago
8K
ONCY
Oncolytics secures new patent for pelareorep manufacturing
PremiumThe Fly
Oncolytics secures new patent for pelareorep manufacturing
10d ago
ONCY
Oncolytics promotes John McAdory to COO
PremiumThe Fly
Oncolytics promotes John McAdory to COO
24d ago
CGON
ONCY
Oncolytics Biotech Strengthens Leadership with New COO, Director
PremiumCompany Announcements
Oncolytics Biotech Strengthens Leadership with New COO, Director
24d ago
8K
ONCY
Oncolytics Highlights Pelareorep-RAS Combo Preclinical Cancer Results
PremiumCompany Announcements
Oncolytics Highlights Pelareorep-RAS Combo Preclinical Cancer Results
25d ago
8K
ONCY
Oncolytics announces initial data from pelareorep combination study
PremiumThe FlyOncolytics announces initial data from pelareorep combination study
25d ago
ONCY
Oncolytics Biotech to present data at ASCO 2026 on pelareorep
Premium
The Fly
Oncolytics Biotech to present data at ASCO 2026 on pelareorep
1M ago
ONCY
Oncolytics Highlights Pelareorep Immune Activation Data at ASCO
Premium
Company Announcements
Oncolytics Highlights Pelareorep Immune Activation Data at ASCO
1M ago
8K
ONCY
Jason McCarthy Reiterates Buy Rating and Maintains $3 Price Target on Advancing Pelareorep Oncology Pipeline
PremiumRatings
Jason McCarthy Reiterates Buy Rating and Maintains $3 Price Target on Advancing Pelareorep Oncology Pipeline
1M ago
ONCY
Oncolytics Biotech Highlights Strong Pelareorep Data in Colorectal Cancer
PremiumCompany Announcements
Oncolytics Biotech Highlights Strong Pelareorep Data in Colorectal Cancer
2M ago
8K
ONCY
Oncolytics says in alignment with FDA following pelareorep Type C meeting
PremiumThe Fly
Oncolytics says in alignment with FDA following pelareorep Type C meeting
2M ago
ONCY
Oncolytics Biotech Aligns with FDA on Pelareorep Trial
PremiumCompany Announcements
Oncolytics Biotech Aligns with FDA on Pelareorep Trial
2M ago
8K
ONCY
Oncolytics Biotech: Buy Rating on Pelareorep’s Advancing Registrational Path and Oncolytic Virus Sector Tailwinds
PremiumRatingsOncolytics Biotech: Buy Rating on Pelareorep’s Advancing Registrational Path and Oncolytic Virus Sector Tailwinds
3M ago
ONCY
Oncolytics price target lowered to $5 from $7 at Lake Street
Premium
The Fly
Oncolytics price target lowered to $5 from $7 at Lake Street
3M ago
ONCY
Oncolytics Biotech Establishes $75 Million ATM Offering
Premium
Company Announcements
Oncolytics Biotech Establishes $75 Million ATM Offering
3M ago
8K
ONCY
Oncolytics Plans FDA Meeting for Pelareorep SCAC Study
PremiumCompany Announcements
Oncolytics Plans FDA Meeting for Pelareorep SCAC Study
3M ago
8K
ONCY
Oncolytics schedules FDA meeting for pelareorep registrational path
PremiumThe Fly
Oncolytics schedules FDA meeting for pelareorep registrational path
3M ago
ONCY
Oncolytics Biotech Completes Domestication to Nevada with New Governance
PremiumCompany Announcements
Oncolytics Biotech Completes Domestication to Nevada with New Governance
3M ago
8K
ONCY
Oncolytics completes domicile change to the U.S.
PremiumThe Fly
Oncolytics completes domicile change to the U.S.
3M ago
ONCY
Oncolytics files $250M mixed securities shelf
PremiumThe FlyOncolytics files $250M mixed securities shelf
3M ago
ONCY
Oncolytics Biotech Shifts Corporate Domicile to British Columbia
Premium
Company Announcements
Oncolytics Biotech Shifts Corporate Domicile to British Columbia
3M ago
8K
ONCY
Oncolytics Biotech Showcases Pelareorep as Immune-Priming Backbone With New AACR 2026 Data
Premium
Company Announcements
Oncolytics Biotech Showcases Pelareorep as Immune-Priming Backbone With New AACR 2026 Data
3M ago
ONCY

Trending

Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >